The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 04, 2020

Filed:

Sep. 04, 2018
Applicant:

Wayne State University, Detroit, MI (US);

Inventors:

Jianjun Wang, Troy, MI (US);

Qianqian Li, Troy, MI (US);

Michael Chopp, Southfield, MI (US);

Feng Jiang, Troy, MI (US);

Guojun Wu, Northville, MI (US);

Assignee:

Wayne State University, Detroit, MI (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 47/59 (2017.01); C12N 5/074 (2010.01); A61K 9/00 (2006.01); A61K 47/54 (2017.01); A61K 48/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/59 (2017.08); A61K 9/0019 (2013.01); A61K 38/1709 (2013.01); A61K 47/543 (2017.08); A61K 48/0041 (2013.01); C12N 5/0696 (2013.01); A61K 38/00 (2013.01); C12N 2501/602 (2013.01); C12N 2501/603 (2013.01); C12N 2501/605 (2013.01); C12N 2502/30 (2013.01); C12N 2506/30 (2013.01);
Abstract

Methods for treating a subject in need thereof are provided which include administering a pharmaceutical composition comprising a protein transduction reagent-modified reprogramming protein to the subject, wherein the protein transduction reagent is non-covalently bound to the reprogramming protein and wherein the protein transduction reagent comprises a cation reagent and a lipid. According to aspects, such methods provide delivery of protein-transduction reagent-modified reprogramming proteins to cancer cells, such as tumor cells, as well as diseased cells of diseased tissues and provide in vivo conversion of diseased cells into normal cells via protein-induced in situ cell reprogramming without administration of nucleic acids to the subject.


Find Patent Forward Citations

Loading…